AU Patent

AU2017202884B2 — Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders

Assigned to Avanir Pharmaceuticals Inc · Expires 2018-11-01 · 8y expired

What this patent protects

H:\rInte n\NRPortbl\DCC\RBR\14189400 I.doex-28/04/2017 Abstract Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine. WO 2004/006930 PCT/US200310223…

USPTO Abstract

H:\rInte n\NRPortbl\DCC\RBR\14189400 I.doex-28/04/2017 Abstract Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine. WO 2004/006930 PCT/US20031022303 Figure 1. 2D* 30DW30Q DM Q SUBSTITUTE SHEET (RULE 26)

Drugs covered by this patent

Patent Metadata

Patent number
AU2017202884B2
Jurisdiction
AU
Classification
—
Expires
2018-11-01
Drug substance claim
No
Drug product claim
No
Assignee
Avanir Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.